financetom
Business
financetom
/
Business
/
Illinois Tool Works Tightens Profit Outlook As US Tariffs Stir Supply Concerns
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Illinois Tool Works Tightens Profit Outlook As US Tariffs Stir Supply Concerns
Oct 24, 2025 7:30 AM

Illinois Tool Works Inc. stock fell Friday after it reported third-quarter fiscal 2025 results and narrowed its full-year guidance.

Revenue rose 2.3% year over year (Y/Y) to $4.06 billion, missing the street view of $4.08 billion. The company saw organic revenue growth of 1% Y/Y in the quarter.

Segment Revenue Highlights

Revenue grew 7.3% in the Automotive OEM segment, 2.5% in Food Equipment, 0.3% in Test & Measurement and Electronics, and 3.3% in Welding and 3.3% in Specialty Products segments.

Also Read: This Illinois Tool Works ( ITW ) Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday

The company posted earnings of $2.81 per share, versus $3.91 a year ago and above the consensus estimate of $2.71.

Profitability and Cash Flow

Operating income for the quarter increased 6% Y/Y to $1.1 billion.

The company’s operating margin improved 90 bps Y/Y to 27.4%, with enterprise initiatives contributing 140 bps and six out of seven segments showing expansion.

Operating cash flow stood at $1 billion, and free cash flow came in at $904 million.

During the quarter, the company bought back $375 million in shares and raised the dividend by 7% to an annualized payout of $6.44 per share.

Outlook

Anticipating supply chain disruptions caused by U.S. tariffs, Illinois Tool Works ( ITW ) narrowed its full-year profit outlook, Reuters reported.

The company has tightened its full-year 2025 GAAP EPS guidance to the range of $10.40-$10.50 (versus consensus of $10.40) from $10.35-$10.55 prior.

Illinois Tool Works ( ITW ) projected full-year 2025 sales between $16.057 billion and $16.375 billion (versus consensus of $16.076 billion).

The company projects overall revenue growth of 1% to 3%, with an organic growth of flat to 2%. This outlook reflects the current demand environment, assuming ongoing pricing and supply chain actions successfully offset tariff costs and incorporating current foreign exchange rates.

Operating margin is expected to be between 26% and 27%, with enterprise initiatives contributing 125 basis points or more.

Investors can gain exposure to the stock via Tidal Trust III VistaShares Target 15 USA Quality Income ETF and Honeytree U.S. Equity ETF ( BEEZ ) .

Price Action: ITW shares were trading lower by 4.82% to $245.02 at last check Wednesday.

Read Next:

Dover Lifts Outlook As CEO Sees Strong Order Momentum Into Next Year

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved